Browsing by Subject Yellow Fever Vaccine

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters: 
  Restrict to items in
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 20 of 88
PreviewIssue DateTitleAuthor(s)Document no.
EB20_Min-2_spa.pdf.jpg1957Acta resumida de la segunda sesiónConsejo Ejecutivo, 20EB20/Min/2
wer7629.pdf.jpg2001Adverse events following yellow fever vaccination--
bu0327.pdf.jpg2001Antibody response to 17D yellow fever vaccine in Ghanaian infants / M. Osei-Kwasi ... [et al.]Osei-Kwasi, Mubarak; Dunyo, S. K; Koram, K. A; Afari, E. A; Odoom, J. K; Nkrumah, F. K-
EB12_10_eng.pdf.jpg1953Application for approval by WHO of the yellow fever vaccine produced by the Commonwealth Serum Laboratories, Commonwealth Department of Health, Melbourne (Australia)Executive Board, 12EB12/10
EB11_57_eng.pdf.jpg1953Application for full approval by WHO of the yellow fever vaccine produced by the Wellcome Research Laboratories at Beckenham, Kent (UK)Executive Board, 11EB11/57
EB5_16_eng.pdf.jpg1949Application for full approval by WHO of the yellow fever vaccines produced at the yellow fever laboratories in Bogota and Rio de JaneiroExecutive Board, 5EB5/16
EB2_6_eng.pdf.jpg1948Application for the designation of the Haffkine Institute, Bombay, as an institute approved for carrying out potency tests on yellow fever vaccines: report by the Director-GeneralExecutive Board, 2EB2/6
EB4_20_eng.pdf.jpg1949Application for WHO approval of the yellow fever vaccine manufactured at the Institut Pasteur, ParisExecutive Board, 4EB4/20
EB13R51_fre.pdf.jpg1954Approbation de vaccin antiamarilConseil exécutif, 13EB13.R51
EB12R5_fre.pdf.jpg1953Approbation de vaccin antiamarilConseil exécutif, 12EB12.R5
EB11R23_eng.pdf.jpg1953Approval of yellow-fever vaccineExecutive Board, 11EB11.R23
EB13R51_eng.pdf.jpg1954Approval of yellow-fever vaccineExecutive Board, 13EB13.R51
EB12R5_eng.pdf.jpg1953Approval of yellow-fever vaccineExecutive Board, 12EB12.R5
VIR_RC_74.32_Arbo_eng.pdf.jpg1974Collaborative studies - WHO programme : meeting of directors of WHO reference centres for arboviruses, chlamydiae and rickettsiae, Geneva, 1-5 April 1974Brès, P.L.J.; World Health OrganizationVIR/RC/74.32 (Arbo)
EB20R12_spa.pdf.jpg1957Comité de Expertos en Vacuna Antiamarílica: primer informeConsejo Ejecutivo, 20EB20.R12
EB20R12_fre.pdf.jpg1957Comité d'experts du Vaccin antiamaril : Premier rapportConseil exécutif, 20EB20.R12
EB20_8_fre.pdf.jpg1957Comité d'Experts du Vaccin antiamaril: premier rapportConseil exécutif, 20EB20/8
WHO_HSE_PED_CED_2015.1_eng.pdf.jpg2015Communication and social mobilization in yellow fever mass vaccination campaigns: 10 points from field experienceWorld Health OrganizationWHO/HSE/PED/CED/2015.1
WHO_HSE_PED_CED_2015.1_fre.pdf.jpg2015Communication et mobilisation sociale dans les campagnes de vaccination contre la fièvre jaune : 10 points basés sur l’expérience de terrainOrganisation mondiale de la SantéWHO/HSE/PED/CED/2015.1
Official_record46_fre.pdf.jpg1953Conseil exécutif onzième session tenue á Genève du 12 janvier au 4 février 1953: résolutions: rapport du Conseil exécutif y compris le rapport sur le projet de programme et de budget pour 1954: annexesConseil exécutif, 11-
Showing results 1 to 20 of 88